Dexamethasone, Rituximab, and Cyclophosphamide ± Bortezomib as First-Line Treatment for Waldenström's Macroglobulinemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia
J. Clin. Oncol 2023 Feb 10;[EPub Ahead of Print], C Buske, MA Dimopoulos, A Grunenberg, E Kastritis, C Tomowiak, B Mahé, X Troussard, R Hajek, A Viardot, O Tournilhac, T Aurran, S Lepretre, H Zerazhi, B Hivert, V Leblond, S de Guibert, L Brandefors, R Garcia-Sanz, M Gomes da Silva, E Kimby, B Schmelzle, D Kaszynski, J Dreyhaupt, R Muche, P MorelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.